-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
المؤلفون: Okeke CAV; Department of Dermatology, Howard University College of Medicine, Washington, DC, USA., Seltzer JA; Department of Dermatology, Howard University College of Medicine, Washington, DC, USA., De Guzman CB; University of California Davis School of Medicine, Sacramento, California, USA., Tran JH; Howard University College of Medicine, Washington, DC, USA., Okoye GA; Department of Dermatology, Howard University College of Medicine, Washington, DC, USA., Byrd AS; Department of Dermatology, Howard University College of Medicine, Washington, DC, USA., Wu PA; Department of Dermatology, University of California Davis School of Medicine, Sacramento, California, USA.
المصدر: Contact dermatitis [Contact Dermatitis] 2024 Aug; Vol. 91 (2), pp. 139-145. Date of Electronic Publication: 2024 May 23.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 7604950 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0536 (Electronic) Linking ISSN: 01051873 NLM ISO Abbreviation: Contact Dermatitis Subsets: MEDLINE
مواضيع طبية MeSH: Hair Preparations*/adverse effects , Hair Preparations*/chemistry , Allergens*/adverse effects , Allergens*/analysis , Dermatitis, Allergic Contact*/etiology, Humans ; Betaine/analogs & derivatives ; Betaine/adverse effects ; Betaine/analysis ; Tea Tree Oil/adverse effects ; Tea Tree Oil/analysis ; Perfume/adverse effects ; Perfume/analysis ; Propylene Glycol/adverse effects ; Propylene Glycol/analysis ; Female
-
5دورية أكاديمية
المؤلفون: Casas A Jr; Initiative for Maximizing Student Development Program, University of California-San Diego, La Jolla, California, USA Arturo.CasasJr@UTSouthwestern.edu dcauvi@health.ucsd.edu., Hawisher D; Division of Trauma, Critical Care, Burns and Acute Care Surgery, Department of Surgery, School of Medicine, University of California-San Diego, La Jolla, California, USA., De Guzman CB; Division of Trauma, Critical Care, Burns and Acute Care Surgery, Department of Surgery, School of Medicine, University of California-San Diego, La Jolla, California, USA., Bickler SW; Division of Trauma, Critical Care, Burns and Acute Care Surgery, Department of Surgery, School of Medicine, University of California-San Diego, La Jolla, California, USA.; Division of Pediatric Surgery, Rady Children's Hospital, San Diego, California, USA., De Maio A; Initiative for Maximizing Student Development Program, University of California-San Diego, La Jolla, California, USA.; Division of Trauma, Critical Care, Burns and Acute Care Surgery, Department of Surgery, School of Medicine, University of California-San Diego, La Jolla, California, USA.; Department of Neurosciences, School of Medicine, University of California-San Diego, La Jolla, California, USA., Cauvi DM; Division of Trauma, Critical Care, Burns and Acute Care Surgery, Department of Surgery, School of Medicine, University of California-San Diego, La Jolla, California, USA Arturo.CasasJr@UTSouthwestern.edu dcauvi@health.ucsd.edu.
المصدر: Infection and immunity [Infect Immun] 2021 Mar 17; Vol. 89 (4). Date of Electronic Publication: 2021 Mar 17 (Print Publication: 2021).
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0246127 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1098-5522 (Electronic) Linking ISSN: 00199567 NLM ISO Abbreviation: Infect Immun Subsets: MEDLINE
مواضيع طبية MeSH: Disease Susceptibility*, Adaptor Proteins, Signal Transducing/*genetics , Adaptor Proteins, Signal Transducing/*metabolism , I-kappa B Proteins/*metabolism , Sepsis/*etiology , Sepsis/*metabolism , Shock, Septic/*etiology , Shock, Septic/*metabolism, Animals ; Animals, Outbred Strains ; Disease Models, Animal ; Lipocalin-2/genetics ; Lipocalin-2/metabolism ; Lipopolysaccharides/adverse effects ; Macrophages/immunology ; Macrophages/metabolism ; Mice ; Sepsis/pathology ; Shock, Septic/pathology
-
6دورية أكاديمية
المؤلفون: Deeb LC; Department of Pediatrics, Florida State University College of Medicine, Tallahassee, Florida., Dulude H; Clinical Development, Locemia Solutions, Montreal, Québec, Canada., Guzman CB; Medical Development, Diabetes Business Unit, Formerly Eli Lilly and Company, Indianapolis, Indiana., Zhang S; Statistics, Eli Lilly and Company, Indianapolis, Indiana., Reiner BJ; Clinical Development, Pediatric Endocrine Private Practice, Baltimore, Maryland., Piché CA; Clinical Development, Locemia Solutions, Montreal, Québec, Canada., Pradhan S; Global Scientific Communications, Diabetes Business Unit, Eli Lilly Services India Pvt. Ltd., Bangalore, Karnataka, India., Zhang XM; Medical Development, Diabetes Business Unit, Eli Lilly Canada Inc., Toronto, Ontario, Canada.
المصدر: Pediatric diabetes [Pediatr Diabetes] 2018 Aug; Vol. 19 (5), pp. 1007-1013. Date of Electronic Publication: 2018 Mar 22.
نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Munksgaard Country of Publication: Denmark NLM ID: 100939345 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1399-5448 (Electronic) Linking ISSN: 1399543X NLM ISO Abbreviation: Pediatr Diabetes Subsets: MEDLINE
مواضيع طبية MeSH: Diabetes Mellitus, Type 1/*complications , Glucagon/*administration & dosage , Hormones/*administration & dosage , Hypoglycemia/*drug therapy, Administration, Intranasal ; Adolescent ; Caregivers/psychology ; Child ; Diabetes Mellitus, Type 1/drug therapy ; Female ; Humans ; Hypoglycemia/chemically induced ; Insulin/adverse effects ; Male ; Prospective Studies ; Treatment Outcome
-
7دورية أكاديمية
المؤلفون: Seaquist ER; University of Minnesota, Minneapolis, Minnesota., Dulude H; Locemia Solutions, Montreal, Québec, Canada., Zhang XM; Medical Development, Diabetes Business Unit, Eli Lilly Canada Inc, Toronto, Ontario, Canada., Rabasa-Lhoret R; Montreal Clinical Research Institute, Montreal, Québec, Canada., Tsoukas GM; McGill University Health Center, Montreal, Québec, Canada., Conway JR; Canadian Centre for Research on Diabetes, Smiths Falls, Ontario, Canada., Weisnagel SJ; CHU de Québec-Université Laval, Quebec City, Québec, Canada., Gerety G; Division of Community Endocrinology, Albany Medical College, Albany, New York., Woo VC; University of Manitoba, Winnipeg, Manitoba, Canada., Zhang S; Statistics, Eli Lilly and Company, Indianapolis, Indiana., Carballo D; Locemia Solutions, Montreal, Québec, Canada., Pradhan S; Global Scientific Communications, Diabetes Business Unit, Eli Lilly Services India Pvt. Ltd, Bangalore, India., Piché CA; Locemia Solutions, Montreal, Québec, Canada., Guzman CB; Medical Development, Diabetes Business Unit, Formerly Eli Lilly and Company, Indianapolis, Indiana.
المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2018 May; Vol. 20 (5), pp. 1316-1320. Date of Electronic Publication: 2018 Mar 22.
نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
مواضيع طبية MeSH: Diabetes Mellitus, Type 1/*drug therapy , Glucagon/*administration & dosage , Hypoglycemia/*drug therapy , Hypoglycemic Agents/*adverse effects , Insulin/*adverse effects, Administration, Intranasal ; Adult ; Blood Glucose/analysis ; Blood Glucose Self-Monitoring ; Caregivers ; Female ; Glucagon/therapeutic use ; Health Knowledge, Attitudes, Practice ; Humans ; Hypoglycemia/blood ; Hypoglycemia/chemically induced ; Hypoglycemia/physiopathology ; Hypoglycemic Agents/therapeutic use ; Insulin/therapeutic use ; Lost to Follow-Up ; Male ; Middle Aged ; Patient Dropouts ; Patient Education as Topic ; Self Report ; Severity of Illness Index ; Syncope/etiology ; Syncope/prevention & control ; Time Factors
-
8دورية أكاديمية
المؤلفون: Guzman CB; Eli Lilly and Company Indianapolis IN.; Present address: Enanta Pharmaceuticals Inc Watertown MA., Duvvuru S; Eli Lilly and Company Indianapolis IN.; Present address: Amazon Seattle WA., Akkari A; Cabernet Pharmaceuticals Durham NC., Bhatnagar P; Eli Lilly and Company Indianapolis IN., Battioui C; Eli Lilly and Company Indianapolis IN., Foster W; Eli Lilly and Company Indianapolis IN., Zhang XM; Eli Lilly and Company Toronto Canada., Shankar SS; Eli Lilly and Company Indianapolis IN.; Present address: NGM Biopharmaceuticals San Francisco CA., Deeg MA; Eli Lilly and Company Indianapolis IN.; Present address: Regulus Pharmaceuticals San Diego CA., Chalasani N; Indiana University Department of Medicine Indianapolis IN., Hardy TA; Eli Lilly and Company Indianapolis IN., Kazda CM; Eli Lilly and Company Neuilly sur Seine France., Pillai SG; Eli Lilly and Company Indianapolis IN.
المصدر: Hepatology communications [Hepatol Commun] 2018 Mar 23; Vol. 2 (5), pp. 561-570. Date of Electronic Publication: 2018 Mar 23 (Print Publication: 2018).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101695860 Publication Model: eCollection Cited Medium: Internet ISSN: 2471-254X (Electronic) Linking ISSN: 2471254X NLM ISO Abbreviation: Hepatol Commun Subsets: PubMed not MEDLINE
-
9دورية أكاديمية
المؤلفون: Guzman CB; Eli Lilly and Company, Indianapolis, Indiana., Dulude H; Locemia Solutions, Montréal, Québec, Canada., Piché C; Locemia Solutions, Montréal, Québec, Canada., Rufiange M; Algorithme Pharma Inc., Montréal, Québec, Canada., Sadoune AA; Algorithme Pharma Inc., Montréal, Québec, Canada., Rampakakis E; JSS Medical Research, Montréal, Québec, Canada., Carballo D; Locemia Solutions, Montréal, Québec, Canada., Triest M; Locemia Solutions, Montréal, Québec, Canada., Zhang MX; Eli Lilly Canada Inc., Toronto, Ontario, Canada., Zhang S; Eli Lilly and Company, Indianapolis, Indiana., Tafreshi M; JSS Medical Research, Montréal, Québec, Canada., Sicard E; Algorithme Pharma Inc., Montréal, Québec, Canada.
المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2018 Mar; Vol. 20 (3), pp. 646-653. Date of Electronic Publication: 2017 Nov 19.
نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
مواضيع طبية MeSH: Common Cold/*complications , Gastrointestinal Agents/*administration & dosage , Glucagon/*administration & dosage , Nasal Decongestants/*pharmacology, Administration, Intranasal ; Adult ; Blood Glucose/drug effects ; Blood Glucose/metabolism ; Female ; Gastrointestinal Agents/pharmacokinetics ; Gastrointestinal Agents/pharmacology ; Glucagon/pharmacokinetics ; Glucagon/pharmacology ; Healthy Volunteers ; Humans ; Hypoglycemia/drug therapy ; Male ; Nasal Obstruction/complications ; Powders
-
10دورية أكاديمية
المؤلفون: Guzman CB; Eli Lilly and Company, Indianapolis, Indiana., Zhang XM; Eli Lilly Canada Inc, Toronto, Ontario, Canada., Liu R; Eli Lilly and Company, Indianapolis, Indiana., Regev A; Eli Lilly and Company, Indianapolis, Indiana., Shankar S; Eli Lilly and Company, Indianapolis, Indiana., Garhyan P; Eli Lilly and Company, Indianapolis, Indiana., Pillai SG; Eli Lilly and Company, Indianapolis, Indiana., Kazda C; Eli Lilly and Company, Neuilly-sur-Seine, France., Chalasani N; Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana., Hardy TA; Eli Lilly and Company, Indianapolis, Indiana.
المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2017 Nov; Vol. 19 (11), pp. 1521-1528. Date of Electronic Publication: 2017 Jun 08.
نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
مواضيع طبية MeSH: Biphenyl Compounds/*adverse effects , Diabetes Mellitus, Type 2/*drug therapy , Fatty Liver/*chemically induced , Liver/*drug effects , Liver/*metabolism, Adult ; Aged ; Biphenyl Compounds/therapeutic use ; Diabetes Mellitus, Type 2/complications ; Fatty Liver/pathology ; Female ; Humans ; Hypoglycemia/chemically induced ; Hypoglycemia/pathology ; Lipid Metabolism/drug effects ; Liver/pathology ; Male ; Middle Aged ; Receptors, Glucagon/antagonists & inhibitors